PZ Cormay Past Earnings Performance

Past criteria checks 0/6

PZ Cormay's earnings have been declining at an average annual rate of -28.4%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been declining at an average rate of 4.6% per year.

Key information

-28.4%

Earnings growth rate

-27.3%

EPS growth rate

Medical Equipment Industry Growth25.3%
Revenue growth rate-4.6%
Return on equity-8.5%
Net Margin-5.7%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

Fewer Investors Than Expected Jumping On PZ Cormay S.A. (WSE:CRM)

Sep 08
Fewer Investors Than Expected Jumping On PZ Cormay S.A. (WSE:CRM)

There's Been No Shortage Of Growth Recently For PZ Cormay's (WSE:CRM) Returns On Capital

Feb 27
There's Been No Shortage Of Growth Recently For PZ Cormay's (WSE:CRM) Returns On Capital

PZ Cormay (WSE:CRM) Is Experiencing Growth In Returns On Capital

Sep 15
PZ Cormay (WSE:CRM) Is Experiencing Growth In Returns On Capital

Revenue & Expenses Breakdown

How PZ Cormay makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

WSE:CRM Revenue, expenses and earnings (PLN Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2384-5354
30 Jun 2387-1364
31 Mar 2385-3364
31 Dec 2285-7353
30 Sep 2288-4344
30 Jun 2287-7344
31 Mar 2286-2323
31 Dec 21852313
30 Sep 2181-4302
30 Jun 2175-3291
31 Mar 2168-4281
31 Dec 2065-13290
30 Sep 2063-46310
30 Jun 2067-46320
31 Mar 2069-50330
31 Dec 1968-41330
30 Sep 1970-27320
30 Jun 1966-25320
31 Mar 1968-22330
31 Dec 1870-25330
30 Sep 1871-1330
30 Jun 1871-1330
31 Mar 1874-1340
31 Dec 1778-2350
30 Sep 1776-13360
30 Jun 1779-14360
31 Mar 1781-13360
31 Dec 1682-11360
30 Sep 1675-3320
30 Jun 1668-3270
31 Mar 1655-7250
31 Dec 1545-25200
30 Sep 1557-56300
30 Jun 1567-55362
31 Mar 1584-60402
31 Dec 1499-42462
30 Sep 14104-10397
30 Jun 14104-9376
31 Mar 141021345
31 Dec 131012355

Quality Earnings: CRM is currently unprofitable.

Growing Profit Margin: CRM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if CRM's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare CRM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CRM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.7%).


Return on Equity

High ROE: CRM has a negative Return on Equity (-8.48%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies